Galactosemia Screening

Galactosemia Screening is a clinical diagnostic method within the domain of metabolic disorder testing that specifically identifies individuals with galactosemia by detecting abnormal levels of galactose or its metabolites in biological samples, thereby enabling early intervention in newborns and at-risk populations.

133

Publications

4.4K

Citations

520

Authors

207

Institutions

Publications per year

2017–2026

7

Authors

520

  1. EB
    Ernest Beutler

    City Of Hope National Medical Center, United States

    6 publications · 451 citations

    6

    h-index

  2. GT
    Gerard T. Berry

    Boston Children's Hospital, United States

    5 publications · 145 citations

    5

    h-index

  3. GN
    George N. Donnell

    Children's Hospital of Los Angeles, United States

    4 publications · 146 citations

    4

    h-index

  4. AM
    Annet M. Bosch

    University of Amsterdam, Netherlands

    4 publications · 134 citations

    4

    h-index

  5. LJ
    Louis J. Elsas

    Emory University, United States

    4 publications · 174 citations

    4

    h-index

1–5 of 520

Venues

  1. PubMed

    Repository · 21 publications · 829 citations

    14

    h-index

  2. Journal of Inherited Metabolic Disease

    JIMD · 8 publications · 197 citations

    8

    h-index

  3. PEDIATRICS

    8 publications · 203 citations

    8

    h-index

  4. Clinical Chemistry

    7 publications · 261 citations

    7

    h-index

  5. Pediatric Research

    5 publications · 167 citations

    5

    h-index

1–5